Access Vascular Gets FDA Clearance for Its HydroPICC Dual-Lumen Catheter

Billerica, Mass.-based Access Vascular has received the FDA’s 510(k) clearance for its HydroPICC dual-lumen catheter.

The PICC (peripherally inserted central catheter) device is used to deliver drugs to hospital patients. Made from a proprietary hydrophilic biomaterial, the catheter is available in multiple kit configurations.

In recent studies, use of the newly cleared catheter led to significant reductions in complications such as occlusions, replacements, deep vein thrombosis and phlebitis, the company said.  

The biomaterial-based catheter enables more patients to “benefit from uninterrupted treatment and less risk of complications,” the company added.